Condition: Attention-Deficit/Hyperactivity Disorder · Autism Spectrum Disorder · Sponsor: Neudive Inc.
The purpose of this study is to explore the preliminary safety and effectiveness of the digital therapeutic device 'NDTx-02' in supporting improvements of executive function in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD).
This description comes directly from the study's public registry record.
SungJa Cho · +82-2-6959-9933 · sungja_cho@neudive.com
Always discuss trial participation with your own doctor first.
| Daegu Catholic University Medical Center | Daegu, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| The Catholic University of Korea, Seoul St. Mary's Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07242625